ERCAN, M. B. Et Al. 2024. Responsiveness to pembrolizumab in severe early-onset natalizumab associated PML-IRIS in patient with relapsing-remitting multiple sclerosis. MULTIPLE SCLEROSIS JOURNAL , vol.30, no.6 , 760-762.

ERCAN, M. B., KOÇER, E. B., ALTIPARMAK, T., & ARSLAN, İ., (2024). Responsiveness to pembrolizumab in severe early-onset natalizumab associated PML-IRIS in patient with relapsing-remitting multiple sclerosis. MULTIPLE SCLEROSIS JOURNAL , vol.30, no.6, 760-762.

ERCAN, MERVE Et Al. "Responsiveness to pembrolizumab in severe early-onset natalizumab associated PML-IRIS in patient with relapsing-remitting multiple sclerosis," MULTIPLE SCLEROSIS JOURNAL , vol.30, no.6, 760-762, 2024

ERCAN, MERVE B. Et Al. "Responsiveness to pembrolizumab in severe early-onset natalizumab associated PML-IRIS in patient with relapsing-remitting multiple sclerosis." MULTIPLE SCLEROSIS JOURNAL , vol.30, no.6, pp.760-762, 2024

ERCAN, M. B. Et Al. (2024) . "Responsiveness to pembrolizumab in severe early-onset natalizumab associated PML-IRIS in patient with relapsing-remitting multiple sclerosis." MULTIPLE SCLEROSIS JOURNAL , vol.30, no.6, pp.760-762.

@article{article, author={MERVE BAHAR ERCAN Et Al. }, title={Responsiveness to pembrolizumab in severe early-onset natalizumab associated PML-IRIS in patient with relapsing-remitting multiple sclerosis}, journal={MULTIPLE SCLEROSIS JOURNAL}, year=2024, pages={760-762} }